Slots: Each institution is allowed a maximum of one nomination per grant cycle to one of the Pathway Program Award types: Initiator or Accelerator. Institutions may not submit nominations in multiple award types in a single grant cycle.
Internal Deadline: Friday, June 9, 2023, 5pm PT
External Deadline: August 1, 2023, 2pm PT (5pm ET)
Award Type: Grant
Anticipated Award Amount: Up to $100,000 year in Phase 1, up to $325,000/year in Phase 2. Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.
Who May Serve as Applicant: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Candidate’s appointment at the Sponsoring Institution must be full-time. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by Pathway administration staff prior to application submission.
Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
Applicant fellowship positions must be at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission.
Recipients of Initiator Awards cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency).
One person must be specified as the PI; co-PIs are not permitted.
Initiator applicants must agree to devote at least 75% of total time and effort towards research during the period of Association funding with a commitment to the Initiator Award of 75-100% effort during Phase 1 and 50-75% effort during Phase 2 if funded. In other words, 75% of the PI’s time overall must be dedicated to research. This percentage includes time dedicated to the Association-funded grant in addition to grants supported by other funding agencies.
Applicants are required to provide an Institutional Nomination Letter from the appropriate institutional representative responsible for the final approval of the nomination submission (Chair of Nominating Committee, Dean of Research, Division Head, etc.), co-signed by the applicant’s Division or Department Head, delineating the institution’s nomination and commitment to the applicant. In addition, applicants must provide a completed Nomination Form, signed by the appropriate institutional representatives, acknowledging the nomination and endorsing the grant application (see Sponsoring Institution Stipulations below). Nomination materials must be submitted through the Association’s online Grant Management Site at the time of application. The Association will not accept such materials separately after the application deadline. Applications submitted without the appropriate nomination forms are considered incomplete and will be administratively disapproved.
Link to Award: https://professional.diabetes.org/content-page/current-funding-opportunities-pathway-stop-diabetes
Process for Limited Submissions
PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/. Use the template provided here: RII Limited Submission Applicant Template
Materials to submit include:
- (1) Two-Page Proposal Summary (1” margins; single-spaced; standard font type, e.g. Arial, Helvetica, Times New Roman, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
- (2) CV – (5 pages maximum)
Note: The portal requires information about the PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
The Pathway Initiator award is designed to support early career researchers who have distinguished themselves during their research training as exceptionally talented and promising research investigators with a high likelihood of establishing successful, independent research programs and making seminal contributions in diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes with an emphasis on the investigator’s potential to significantly transform diabetes through translational research (‘moving the needle’) to improve the lives of people with diabetes. These awards provide salary and research support for applicants during late stages of mentored training through establishment as independent research faculty.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.